WS
MRKR icon

Wedbush Securities’s Marker Therapeutics MRKR Stock Holding History

Wedbush Securities’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-69,500
Closed -$377K – 1200
2024
Q2 		$377K Buy
69,500
+24,000
+53% +$102K 0.01% 747
2024
Q1 		$196K Sell
45,500
-24,000
-35% -$105K 0.01% 1111
2023
Q4 		$382K Buy
69,500
+11,438
+20% +$38.8K 0.02% 661
2023
Q3 		$264K Buy
58,062
+15,562
+37% +$87K 0.01% 781
2023
Q2 		$132K Buy
42,500
+30,495
+254% +$53K 0.01% 994
2023
Q1 		$9K Buy
12,005
+3,598
+43% +$8.55K ﹤0.01% 1070
2022
Q4 		$22K Sell
8,407
-1,600
-16% -$5.52K ﹤0.01% 1033
2022
Q3 		$37K Hold
10,007
– – ﹤0.01% 1019
2022
Q2 		$33K Buy
10,007
+1,000
+11% +$3.33K ﹤0.01% 1047
2022
Q1 		$40K Buy
9,007
+2,750
+44% +$15.7K ﹤0.01% 1083
2021
Q4 		$59K Sell
6,257
-750
-11% -$9.96K ﹤0.01% 1151
2021
Q3 		$118K Hold
7,007
– – 0.01% 1118
2021
Q2 		$195K Hold
7,007
– – 0.01% 1071
2021
Q1 		$157K Hold
7,007
– – 0.01% 1014
2020
Q4 		$102K Sell
7,007
-2,610
-27% -$40.5K 0.01% 833
2020
Q3 		$144K Sell
9,617
-1,400
-13% -$25.5K 0.01% 795
2020
Q2 		$228K Buy
11,017
+4,010
+57% +$87.7K 0.02% 721
2020
Q1 		$133K Buy
7,007
+500
+8% +$12.7K 0.02% 745
2019
Q4 		$187K Buy
6,507
+850
+15% +$30.9K 0.02% 877
2019
Q3 		$289K Buy
5,657
+3,605
+176% +$213K 0.03% 654
2019
Q2 		$163K Buy
+2,052
New +$122K 0.02% 860

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
AR Asset Management West Hollywood, California $517M AUM 18.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
I
INVST Indianapolis, Indiana $886M AUM 21.79% 1-Year Est. Return

Wedbush Securities's MRKR Position: Q3 2024 in Review

Wedbush Securities sold out of Marker Therapeutics (MRKR) in Q3 2024, closing a stake of 69,500 shares — an estimated $377K sold.

Wedbush Securities first reported a position in MRKR in Q2 2019 and held it in 21 quarters. The position peaked at $382K in Q4 2023. 28 funds tracked by Wall St. Rank hold MRKR as of Q3 2024.

  • Wedbush Securities reported no remaining Marker Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Wedbush Securities sold 69,500 Marker Therapeutics shares in Q3 2024, an estimated $377K.
  • Wedbush Securities first reported a position in Marker Therapeutics in Q2 2019 and held it in 21 quarters.
  • Wedbush Securities's Marker Therapeutics position peaked at $382K in Q4 2023.
  • 28 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2024.

Based on Wedbush Securities's 13F filing for Q3 2024, filed 8 Nov 2024.